Tag:
Immune Design
Latest Headlines
Latest Headlines
Immune Design recruits former Elan exec
Former Elan president Carlos Paya has signed on as Immune Design's new CEO. The Seattle-based vaccine developer, which was founded in 2008, is developing therapeutic vaccines for the treatment of
Immune Design lands $212M adjuvant pact with MedImmune
Seattle vaccine upstart Immune Design scored a $212 million licensing deal and some important industry cred with its new pact giving MedImmune the right to use its adjuvant in new vaccines. The deal
Steve Reed uses familiar strategy to build a new biotech
In a follow-up to yesterday's news that Immune Design had raised a $32 million round to fuel its work on a new generation of vaccines, CEO Steve Reed talked to Xconomy's Luke Timmerman about his
Seattle vaccine developer raises $18M in Series A
Seattle-based Immune Design has raised an impressive $18 million in its first round of venture capital. The vaccine company is developing therapies targeting dendritic cells, which control the human
